Scott Dahlbeck - May 23, 2022 Form 4 Insider Report for Kiromic Biopharma, Inc. (KRBP)

Role
Chief Medical Officer
Signature
/s/ Scott Dahlbeck
Stock symbol
KRBP
Transactions as of
May 23, 2022
Transactions value $
$0
Form type
4
Date filed
5/25/2022, 04:15 PM
Next filing
Aug 15, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KRBP Common Stock Options Exercise +17.2K +4.01% 447K May 23, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KRBP Restricted Stock Units Options Exercise $0 -17.2K -100% $0.00* 0 May 23, 2022 Common Stock 17.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into common stock on a one-for-one basis.
F2 On August 20, 2020, the reporting person was granted 17,420 restricted stock units, vesting on October 16, 2021.